Condition: Glioblastoma · Sponsor: Guangzhou Virotech Pharmaceutical Co., Ltd.
This study is an open-label, single-arm Phase I/II clinical trial with the primary objective of evaluating the safety, tolerability, and efficacy of VRT106 in patients with recurrent/progressive glioblastoma.
This description comes directly from the study's public registry record.
Chengcheng Guo · 020-87343990 · guochch@sysucc.org.cn
Ke Sai · 020-87343890 · saike@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of USTC | Hefei, Anhui, China | Not Yet Recruiting |
| Sanbo Brain Hospital Capital Medical University | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Cancer Hospital Affiliated to Chongqing University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | Recruiting |
| The Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai, Guangdong, China | Recruiting |
| Guangxi Medical University Cancer Hospital | Nanning, Guangxi, China | Recruiting |
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Not Yet Recruiting |
| Tangdu Hospital of Air Force Medical University of the PLA | Xi’an, Shanxi, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07093814